World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03225027
Date of registration: 17/07/2017
Prospective Registration: No
Primary sponsor: Centre Hospitalier René Dubos
Public title: Study on Communication Comprehension in the Schizophrenic Spectrum SKYPROVERB
Scientific title: Study on Communication Comprehension in the Schizophrenic Spectrum
Date of first enrolment: November 15, 2016
Target sample size: 59
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03225027
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Virginie BEAUCOUSIN, PhD
Address: 
Telephone:
Email:
Affiliation:  CRFDP (University of Rouen)
Name:     Mouna TRABELSI, MD
Address: 
Telephone:
Email:
Affiliation:  HDJ François Villon (Centre Hospitaliser René-Dubos)
Key inclusion & exclusion criteria

Inclusion Criteria:

- Having a diagnosis of schizophrenia and being in a stable phase of the disease

- Having between 18 to 60 years old

- Speak french or using french at school

- Accepting not to use psychoactive substances during the preceding 48h

- Being affiliated to the French social security

- Providing their written informed consent

Non-inclusion Criteria:

- Having not audio deficits, nor visual uncorrected deficits

- Having not suffering from depressive symptoms during the last 6 months

Exclusion Criteria:

- Having no neurological, nor psychiatric disease except schizophrenia for the patients
groups.



Age minimum: 18 Years
Age maximum: 60 Years
Gender: All
Health Condition(s) or Problem(s) studied
Schizophrenia Simple
Intervention(s)
Behavioral: Post-experimental questionnaire
Diagnostic Test: Trait Emotional Intelligence Questionnaire
Behavioral: Recognition task
Other: CAPE-42
Behavioral: Detection task
Behavioral: Emotional judgment task
Diagnostic Test: Positive And Negative Syndrome Scale
Other: Mini International Neuropsychiatric Interview
Primary Outcome(s)
Behavioural measures (response rate and time) [Time Frame: During the experiment]
Secondary Outcome(s)
Symptomatic impact [Time Frame: During the experiment]
Evaluate the cognitive functioning [Time Frame: During the experiment]
Secondary ID(s)
CHRD0814
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history